Read article – Continued coverage of comments by Matthew Friedman, professor of psychiatry and of pharmacology and toxicology, about a new study on the effectiveness of the drug prazosin, which thousands of people with post-traumatic stress disorder have taken to ease their sleep. “I really think that we are beginning to recognize that sweeping everything under one PTSD rug may be more than one rug can cover, or should cover,” says Friedman, who was not involved in the study. “By better defining what the syndrome is that we’re treating, we can better identify medications that could be helpful.”

Read article – Quotes Damian Almiron Bonnin, an MD-PhD student, about research he led that successfully uncovered a therapeutic approach that targets aggressive brain cancer stem cells and could lead to improved patient survival. “The presence of glioma stem cells within high-grade gliomas is one of the reasons they are so difficult to treat,” says Almiron Bonnin.

Read article – As a guest on “The Exchange,” Jacob Borodovsky, a PhD candidate at the Dartmouth Institute for Health Policy and Clinical Practice, discusses New Hampshire’s medical marijuana program.

Read article – Quotes Matthew Friedman, professor of psychiatry and of pharmacology and toxicology, about a new study on the effectiveness of the drug prazosin, which thousands of people with post-traumatic stress disorder have taken to ease their sleep. “I really think that we are beginning to recognize that sweeping everything under one PTSD rug may be more than one rug can cover, or should cover,” says Friedman, who was not involved in the study. “By better defining what the syndrome is that we’re treating, we can better identify medications that could be helpful.”

Read article – Continued coverage of research led by Valerie Lewis, associate professor of the Dartmouth Institute for Health Policy and Clinical Practice, about how management partners—from national players like Optum and Walgreens to local groups focused on regions—have played a crucial, if little-scrutinized role in getting accountable care organizations off the ground. Thirty-seven percent of ACOs had a management partner, most of which shared in the financial rewards and risks. (Similar coverage in HealthcareFinance.)

Read article – Quotes Kanak Verma, a dual-degree MD/MPH student, about a new study she coauthored that found that newborns suffering from opioid withdrawal might have shorter hospital stays and less need for medications if they stay in a room with their mother instead of being sent to intensive care. (Picked up by Business Insider.)

Read article – Quotes Valerie Lewis, associate professor of the Dartmouth Institute for Health Policy and Clinical Practice, about a new study she led that examined how small groups of management partner companies are tapping into the money that can be made in setting up and running an ACO. In industry circles, these companies are known as “ACO enablers.”

Read article – Quotes H. Gilbert Welch, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, about the the American Heart Association’s warning on Thursday that breast cancer survivors, especially those treated with common chemotherapies, are at increased risk for heart failure and other cardiovascular diseases. “Treatment-related mortality [from heart disease] is not reliably captured in breast-cancer mortality,” says Welch.

Read article – Quotes H. Gilbert Welch, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, about recent research conducted by the Washington Health Alliance that examined waste in spending in healthcare. Welch notes that the findings come back to “Economics 101.” The medical system is still dominated by a payment system that pays providers for doing tests and procedures. “Incentives matter,” says Welch. “As long as people are paid more to do more they will tend to do too much.”

Read article – Quotes Elliott Fisher, director of the Dartmouth Institute for Health Policy and Clinical Practice, and professor of medicine and of community and family medicine, about Amazon, JP Morgan Chase and Berkshire Hathaway’s announcement that they are teaming up to form a new health insurance company for their employees in the United States.